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Objective: To define risk factors significantly and independently associated with Pseudornonas aeruginosa bacteremia 
and to combine them in a diagnostic index which will define groups of septic patients at low or high risk of bloodstream 
infection caused by k? aeruginosa. 
Methods: Logistic regression analysis was used to identify risk factors associated with pseudomonal bacteremia among 
all patients with bacteremia at St Thomas’ Hospital, London, from 1969 to1989. The coefficients of the final logistic model 
were used to compile a linear model for the diagnosis of pseudomonal bacteremia. The index was validated in another 
set of patients with bacteremia detected at Beilinson Medical Center, Petah Tiqva, Israel, from 1988 to 1991. 
Results: Seven factors were significantly and independently predictive of pseudornonal bacteremia:l) neutropenia; 2) 
previous or current treatment with antibiotics; 3) cytotoxic or corticosteroid treatment; 4) hospital acquisition of infection; 
5) detection in the intensive care unit; 6) male gender; and 7) focus of infection. High-risk foci were the urinary tract with 
catheter or post-instrumentation, or unknown source. Low-risk foci were bone, joint, meninges, female genital tract and 
upper respiratory tract. The index score divided patients into three groups with increasing likelihood of F! aeruginosa 
bacteremia: I%, 7% and 19%, respectively ( p  = 0.0001). In the validation set, the percentage of F! aeruginosa bacteremia 
in the three respective groups defined by the index were 5%, 18% and 22% ( p  = 0.0001). 
Conclusions: The use of simple clinical and laboratory data known within hours of detection of an infectious episode 
can define patients at high and low risk for F! aeruginosa bacteremia. 
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Pseudornonas aeruginosa accounts for 8 to 15% of 
hospital-acquired and 1 to 7% of community-acquired 
bacteremias [l-51. The mortality associated with 
pseudomonal bloodstream infection is generally higher 
than with other pathogens even when different risk 
factors for mortality are taken into account [3,5,6]. 
Empirical therapy with appropriate antipseudomonal 
agents may reduce mortality [7-91, but it is likely to be 
inappropriate in patients subsequently shown to have I? 
aeruginosa bacteremia than in those with other bacterial 
pathogens [lo]. Thus, prediction of the likelihood of a 
Corresponding author and reprint requests: 
W.R. Gransden, Department of Microbiology, Guy’s Hospital, 
London SEI SRT, United Kingdom 
Tel: +44171 955 4513 Fax: +44171 955 2909 
Accepted 19 October 1995 
pseudomonal infection in a septic patient as early as 
possible (before the results of blood cultures are known) 
may be of utmost importance and would allow 
empirical treatment of patients at high risk for 
bacteremia caused by P aeruginosa to include anti- 
pseudomonal drugs whereas patients at low risk could 
receive narrower-spectrum therapy. 
The aim of the present study was to define the risk 
factors significantly and independently associated with 
P aeruginosa bacteremia and to combine them in an 
index for prediction of the likelihood of pseudomonal 
bloodstream infection. For derivation of the risk 
factors and the index, we used the St Thomas’ Hospital 
bacteremia database [Ill. To show that the risk 
factors and index were general features of pseudomonal 
bacteremia and not related to  one particular geo- 
graphical site, they were validated in another hospital 
in a different country. 
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Population 
The derivation set included all patients with bacteremia 
seen at St Thomas’ Hospital, London, between 1969 
and 1989. The hospital is an 800-bed teaching hospital 
in southeast London which serves the local population, 
commuters and some tertiary referrals. During the 
period of study, there were no specialist departments for 
cancer chemotherapy or burn patients. 
The validation set consisted of all episodes of 
bacteremia detected at Beilinson Medical Center, Petah 
Tiqva, Israel, from March 1988 to September 1992. 
The Medical Center is a 900-bed hospital serving an 
urban population as a first-line facility. It is also a 
referral centre for several hospitals in the vicinity. To 
determine the possible influence of changing patterns 
of bacteremia over time, a second vahdation set was 
used, consisting of those episodes of bacteremia 
detected at St Thomas’ Hospital fiom 1990 to 1993. 
Collection of data 
In both hospitals, collection of clinical and laboratory 
data was performed by medical microbiologists or 
physicians, and started on the day the first blood culture 
was found to be positive for bacterial growth. For each 
patient, demographic information, data concern- 
ing underlying diseases, functional capacity and 
medications were collected. For every episode of 
bacteremia, the presumptive source, the day and ward 
of occurrence, the use of intraurethral, intravascular or 
intratracheal devices, fever and results of the blood 
count and blood chemistry were recorded. During 
follow-up, data were collected on the antibiotic treat- 
ment, results ofblood and other cultures, complications 
of bacteremia, and duration of hospitalization and 
outcome (whether discharge or death) [4,5,10]. 
Blood cultures 
Venous blood (10 d) was obtained aseptically and 
inoculated into a two-bottle set (6A aerobic and 7A 
anaerobic, Becton Dickinson Diagnostic Instrument 
Systems, Towson, MD, USA at St Thomas’ Hospital; 
and 6B aerobic and 7D anaerobic, Johnston, Towson, 
MD at Beilinson Medical Center), and was tested daily 
on a Bactec 460 system at Beilinson and on a Bactec 
660 at St Thomas’ Hospital. 
Definitions 
For this study, bacteremia was defined as an episode in 
a patient judged to be ‘septic’ (febrile 238°C or 
hypothermic <36.2OC, hypotensive or in septic shock, 
with rigors or a ‘septic appearance’) and with positive 
(and not contaminated) blood cultures. Organisms that 
are commonly recovered fiom the environment or the 
skin (mainly coagulase-negative staphylococci and 
aerobic gram-positive rods) were judged to be con- 
taminants unless the clinical findmgs, the results of 
cultures fiom other body sites or the number ofpositive 
sets (2 two) indcated a high probability of true blood- 
stream infection. 
At St Thomas’ Hospital, a bacteremic episode was 
defined as hospital-acquired if the infectious episode to 
which it was related began at any time after admission. 
At Bellinson Medical Center, a bacteremia was defined 
as hospital-acquired if it occurred more than 48 h after 
admission. 
An episode of bacteremia was designated as 
antedated by antibiotic, corticosteroid or cytotoxic 
treatment if the drug(s) had been given for more than 
1 day during the preceding month, and by an invasive 
procedure if performed within the preceding month. 
Empirical antipseudomonal antibiotic treatment was 
considered appropriate if it was started intravenously 
withm 24 h of collection of the first positive blood 
culture, if it included antipseudomonal p-lactams, an 
aminoglycoside or one of the drugs that can be used as 
monotherapy for l? aemginosa (cefiazidime, imipenem 
or a 4-quinolone), and if the isolate was subsequently 
found to be susceptible in vitro to the drug(s) 
administered. 
Data analysis 
Episodes of bacteremia caused by l? amginosa were 
compared with episodes caused by other pathogens. 
The chi-square test was used for statistical analysis of 
contingency tables. As most of the continuous variables 
were not normally distributed, the Wilcoxon rank- 
sum test was used to assess significance of continuous 
variables compared between two classes. A stepwise 
logistic regression procedure (LOGIST) [12] was used 
to establish which variables were independently and 
significantly associated with bacteremia caused by l? 
aemginosa. The coefficients of the final logistic model 
were used to compile a linear model for dagnosis of 
Pseudomonas bacteremia. 
Derivation set 
At St Thomas’ Hospital, there were 4447 episodes of 
clinically significant bacteremia during the period 
of study. Pseudomonas aeruginosa was the causative 
organism in 231 (5.2%). The mortality rate was 46.7% 
(108 of 231) in patients with Pseudomonas bacteremia, 
and 21.0% (885 of 4216) in patients with other 
pathogens (p = 0.0001). Comparisons which were 
statistically significant on univariate analysis (p < 0.1) 
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Table 1 Derivation set: Univariate comparisons of 
Pseudomonas aeruginosa bacteremia vs bacteremias caused by 
other pathogens at St Thomas’ Hospital, London 
Pseudomonas Other 
% (n = 231) 
aeruginosa pathogens p 
% (n = 4216) 
Age > 20 years 93.9 87.6 0.02 
Male gender 68.0 54.6 0.0001 
Service 
Intensive care unit 23.4 9.5 0.0001 
Urology 13.4 7.3 0.03 
d 1 x lo9 cells/L 20.4 4.9 0.0001 
Hospital-acquired 91.8 55.0 0.0001 
Previous/current 
Neutrophil count 
antibiotic treatment 61.9 26.1 0.0001 
Focus of infection: 
High risk 
Urinary tract with 
catheter or post- 
instrumentation 16.5 8.3 0.001 
Unknown 25.1 12.1 0.0002 
Low risk 
Boneljoint 0.0 2.9 0.009 
Female genital tract 0.0 2.7 0.02 
Upper respiratory tract 0.0 0.8 0.2 
Meninges 0.4 3.3 0.02 
Underlying diseases 
Hematological malignancies 20.8 7.1 0.0002 
Cytotoxic or corticosteroid 
treatment 33.3 14.0 0.0002 
Table 2 Derivation set: Factors included in the final 
logistic model as predictors of pseudomonal bacteremia 
Points 
Flisk factor coefficient y2 D index 
Regression for score 
Previous/current 
antibiotic treatment 
Neutrophd count 
d 1 x lo9 cells/L 
Hospital-acquired 
Intensive care unit patient 
High-risk focusa 
Male gender 
Corticosteroid or 
cytotoxic treatment 
Low risk focusb 
0.969 
1.038 
1.211 
0.804 
0.487 
0.31 1 
0.623 
-2.089 
40.3 
20.1 
22.1 
18.9 
9.9 
6.2 
10.9 
28.4 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.0013 
0.0001 
0.004 
1 
1 
1 
1 
0.5 
0.5 
0.5 
-2 
a = high-risk focus: urinary tract with catheter or post- 
instrumentation, or unknown; 
b = low-risk focus: bone, joint, meninges, female genital tract and 
upper respiratory tract. 
are shown in Table 1. On multivariate logistic regres- 
sion analysis, seven factors were associated both 
significantly and independently with bacteremia caused 
by I? aeruginosa: 1) antibiotic treatment in the previous 
month; 2) neutrophil count S 1.0 x lo9 cells/L; 3) 
hospital acquisition; 4) detection of the episode in the 
intensive care unit; 5) male gender; 6) corticosteroid or 
cytotoxic therapy in the previous month; and 7) focus 
of infection. Foci with a high risk included the urinary 
tract with catheter or post-instrumentation, or the 
absence of an identifiable focus; those with a low risk 
were bone, joint, meninges, female genital tract and 
upper respiratory tract (Table 2). 
The regression coefficients were used to compile a 
linear model in which one point was given for hospital 
acquisition, previous or current antibiotic treatment, 
detection of bacteremia in the intensive care unit and 
neutropenia. Half a point was added for male gender, 
corticosteroid or cytotoxic treatment, or the presence 
of a high-risk focus. For a low-risk focus, two points 
were subtracted (Table 2). The percentage of l? 
aeruginosa bacteremia in patients with an index score 
< 2 was 1.3% (37 of 2762 patients), 6.9% (74 of 1064 
patients) with an index score of2 or 3, and 19.3% (120 
of 621 patients) with an index score > 3 (Table 3). 
First validation set 
During the study period, 2705 episodes of bacteremia 
were detected in 2627 patients at Beilinson Medical 
Center. Pseudomonas aeruginosa was isolated in 291 
episodes (10.8%). The risk factors delineated in the St 
Thomas’ data were significantly associated with I? 
aeruginosa bacteremia (Table 4). 
When, divided according to the index score, the 
percentage of Pseudomonas bacteremia in the first group 
Table 3 Performance of the score index in the derivation 
and validation sets: Patients (n) with Pseudomonas aeruginosa 
bacteremia/total patients (n) 
Second validation 
Index First validation set: St Thomas’, 
score Derivation set set: Beilinson’ 1990-1993 
< 2 37/2762 (1.3%) 89/1615 (5.5%) 26/1053 (2.5%) 
2-3 74/1064 (6.9%) 143/815 (17.6%) 661616 (10.7%) 
> 3 120/621 (19.3%) 57/256 (22.3%) 481234 (20.5%) 
p = 0.0001 p = 0.0001 p < 0.0001 
a = Nineteen patients were excluded kom this analysis because of 
missing values for one of the risk factors included in the index. 
One point is given for previous or current antibiotic treatment, 
neutrophil count S 1.0 X lo9 cells/L, hospital acquisition and 
detection in the intensive care unit; haifa point for male gender, 
high-risk focus of infection and corticosteroid or cytotoxic 
treatment; and -2 points for a low-risk focus. 
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(score < 2) was 5.5% compared with 17.6% in the 
second group (score of 2 to 3) and 22.3% in the third 
group (score > 3) (p = 0.0001; Table 3). 
Of 291 episodes of pseudomonal bacteremia, 174 
(59.8%) were given inappropriate empirical antibiotic 
treatment compared with 900 of 2414 episodes (37.3%) 
of bacteremia caused by other pathogens (p = 0.0001). 
Second validation set 
From 1990 to 1993, there were 1903 episodes of 
bacteremia detected at St Thomas’ Hospital and I? 
aemginosa was isolated on 140 occasions (7.4%) (Table 5). 
When divided according to the index score, the 
percentages of Pseudomonas bacteremia among the three 
groups were 2.5%, 10.7% and 20.5% (Table 3). 
Seven risk factors were associated with I? aemginosa 
bacteremia: neutropenia; cytotoxic or corticosteroid 
treatment; male gender; acquisition of infection in the 
hospital; detection of bacteremia in the intensive care 
unit; previous or current antibiotic treatment; and focus 
of infection. High rates of I? aeruginosa bacteremia were 
detected in patients who had evidence of urinary tract 
infection and a urinary catheter, or had undergone an 
invasive procedure of the urinary tract, and in those in 
whom no source of infection could be identified. A 
low risk of I? aemginosa bacteremia w a s  associated with 
a focus ofinfection in the bone, joint, meninges, female 
genital kact or upper respiratory tract. 
Table 4 Validation set: Univariate comparisons of factors in 
patients with Pseudomonac amginosa bacteremia in Beilinson 
Medical Center 
Pseudomom Other 
% (n = 143) 
amginosa pathogens p 
% (n = 1274) 
Gender: Male 
Adult intensive care unit 
Neutmphii count 
c 1 x 109 cells/L 
Hospital-acquired 
Previous/current 
antibiotic treatment 
Focus of infection 
High risk 
Low risk 
Endotracheal intubation 
within previous month 
Present 
Underlying disease 
Corticosteroid or 
imunosuppressive therapy 
63.6 
15.4 
15.4 
60.1 
61.5 
46.8 
0 
15.4 
31.5 
50.8 
6.8 
7.8 
40.3 
37.8 
38.2 
2.1 
7.6 
23.9 
0.004 
~0.0001 
0.002 
<0.0001 
<0.0001 
0.04 
0.08 
0.001 
0.05 
The magnitudes of these associations were 
similar in the two hospitals except for a significantly 
higher percentage of hospital-acquired pseudomonal 
bacteremia at St Thomas’ Hospital. This is probably 
explained by the different definition of hospital- 
acquired bacteremia used in the two hospitals. Never- 
theless, the discriminative power of the index was not 
affected by this difference. Most of these factors have 
also emerged in previous studies [5,7,8,13-191. The 
present study is strengthened by the large number of 
patients surveyed and the use of regression analysis, 
which enabled identification of the factors that are the 
strongest predictors of I? aeruginosa bacteremia. In 
addition, the association of each factor with pseudo- 
monal bacteremia was shown to be independent of 
the contribution of other factors and, finally, the 
magnitude of those associations was quantified. An 
index incorporating these risk factors allowed the 
allocation of patients to one of three groups with 
an increasing rate of I? aeruginosa bacteremia. At St 
Thomas’ Hospital, these percentages were 1%, 7% and 
19% and, at Beilinson Medical Center, 5%, 18% and 
22%. 
Both the risk factors and index retained their 
predictive power when tested in the Behnson database, 
which suggests that the risk factors are not specific to 
one site (St Thomas’ Hospital), but are universally 
associated with l? aemginosa bacteremia. Furthermore, 
the robustness of the index score is demonstrated by 
the finding that its power was maintained over time 
although, from 1990 to 1993, neutropenia was no 
longer associated with pseudomonal infections. It is 
unclear whether this was a result of the occasional use 
Table 5 Second validation set: Univariate comparisons of 
factors in patients with Pseudomonac aewginosa bacteremia in 
St Thomas’ Hospital f h m  1990 to 1993 
Pseudomonas Other 
% (n = 140) 
amginosa pathogens p 
% (n = 1763) 
~ _ _ _ _ _ _  
Gender: Male 61.4 53.1 0.05 
Adult intensive care unit 42.9 18.8 <O.OOOl 
Neutmphd count 
6 1 x lo9 cells/L 7.1 6.4 NS 
Hospital-acquired 88.6 59.3 <O.OOol 
Previous/current 
32.7 <0.0001 antibiotic treatment 69.3 
Focus of infection 
High risk 43.6 24.1 <0.0001 
Low risk 0.7 6.8 0.005 
Underlying disease 
Corticosteroid or 
imunosuppressive therapy 14.3 9.2 0.05 
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of 4-quinolones at St Thomas’ Hospital as prophylaxis 
against infection or whether neutropenia induced by 
cytotoxic therapy was of a shorter duration than in 
previous years. The other associations remained so 
powerful that the performance of the index was not 
affected. Nevertheless, this change emphasizes the need 
to monitor the predictive power of each component of 
a predictive index over time. 
The overall percentage of bacteremic infections 
caused by l? aemginosa is higher at Beilinson Medical 
Center and also within each group defined by the 
index, although the gradation between groups was 
maintained. The actual percentage of Pseudomonas 
bacteremia in each group is dictated by the overall 
frequency of I? aemginosa bacteremia (the ‘pretest 
probability’), which must be borne in mind when the 
index is applied in clinical practice. In any case, a 
patient suspected ofbacteremia and with an index score 
< 2 (first group) should probably not be given empirical 
antipseudomonal treatment whereas the chance of a 
pseudomonal infection in a patient with an index score 
> 3 (third group) is substantial. 
The ‘denominator set’ in this study was a-group of 
patients with proven bacteremia whereas the true 
denominator group in clinical practice should be 
patients suspected of bacteremia. However, in previous 
studies, we and others have shown that the use of 
simple clinical and laboratory data, which are known 
within hours of detection of an infectious episode, can 
define groups of patients a t  high risk for bacteremia 
[20-231. In such patients, the use of the present index 
will probably improve empirical treatment of I? 
aemginosa bacteremia. 
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